Mercado de dispositivos de tratamiento y recolección de sangre capilar en Oriente Medio y África: tendencias de la industria y pronóstico hasta 2030

 Análisis y tamaño del mercado de dispositivos de recolección y muestreo de sangre capilar en Oriente Medio y África

El mercado de los dispositivos de recolección y muestreo de sangre capilar está siendo impulsado por el creciente número de procedimientos quirúrgicos hospitalarios. Los productos de recolección de sangre ayudan a los pacientes que se someten a quimioterapia, diálisis, trasplante de órganos y tejidos y cirugías complejas. Cada vez más personas se someten a controles de salud periódicos debido a la creciente prevalencia de enfermedades crónicas y relacionadas con el estilo de vida sedentario. Como resultado, ha aumentado la demanda de dispositivos de recolección y muestreo de sangre capilar como método principal de diagnóstico de enfermedades.

Data Bridge Market Research analiza que se espera que el mercado de tratamiento de dispositivos de recolección y muestreo de sangre capilar, que es de USD 28,49 millones en 2022, alcance los USD 38,99 millones para 2030, a una CAGR del 4,0% durante el período de pronóstico de 2023 a 2030. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de dispositivos de recolección y muestreo de sangre capilar en Oriente Medio y África  

Market Definition

Capillary blood collection devices are used to extract capillary blood. Capillary blood can be obtained through a finger, earlobe, or heel puncture. It is also possible to make an incision in the skin. Capillary blood collection and sampling techniques have gained popularity because they extract a precise amount of blood while lowering the risk of anaemia. For collecting capillary blood, the volumetric microsampling technique is now widely used. Furthermore, new technological advancements are being made to meet the needs of doctors and patients.

Middle East and Africa Capillary Blood Collection and Sampling Devices Treatment Market Dynamics

Drivers

• Increase in demand for safe blood collection technologies

Clinical diagnostics are important in many medical fields and in healthcare delivery. Blood sample collection is critical to laboratory activities because millions of blood samples are collected each year for chemical and haematological testing to diagnose diseases. The risky practise of blood collection, also known as phlebotomy, can have serious consequences for patients, including fainting, pain at the puncture site, nerve damage, and hematoma. Due to a shortage of skilled professionals, poor venipuncture practise has resulted in anatomical structures near the point of needle entry being injured.

Furthermore, capillary blood testing requires less blood volume and is quick and simple to perform. Physicians and patients prefer capillary blood sampling due to the advantages it has over venous blood sampling. As a result, there is a greater demand for more efficient capillary collection devices, which serves as a market driver.

• The rising availability of POC diagnostics

Point-of-care testing is diagnostic testing performed at the bedside of patients in their homes. It can also be done at any time and from any location. As a result, it is also known as bedside testing. Previously, testing was limited to the laboratories to which the specimen was sent, and obtaining the sample could take anywhere from hours to days. It not only saves time, but it also enables clinicians to provide quality and effective patient care in the patient's home. Because of its advantages, point-of-care diagnostics is becoming more popular.

According to various reports, the total value of the capillary blood collection and sampling devices treatment market was USD 40-45 billion, with POC diagnostics contributing USD 12-13 billion.

The demand for POC testing has increased as health awareness, and the incidence of infectious diseases have increased. Traditional arterial and venous blood collection methods are painful and invasive, with a higher risk of needlestick injuries and contamination if not performed by trained personnel. On the other hand, the capillary blood collection method is less invasive, causes less pain, and has few side effects. Furthermore, it does not necessitate the use of skilled professionals; thus, it is a point care testing technique. Capillary collection devices have advanced in tandem with the rise in POC testing.

Opportunities

• Product innovation and technological advancements in capillary blood collection devices

Blood collection is an important step in the delivery of healthcare. 70% to 80% of clinical decisions are made based on blood sample analysis. Many companies are using safer, easier, and more efficient methods to collect blood samples, thanks to the growing trend of blood collection innovation. For pharmacy clinics, capillary blood sampling is an excellent technique. This method is preferred over venipuncture due to its ease of use and safety; it also eliminates the need for skilled technicians. One disadvantage of finger sticks is that the blood droplets vary in size. This problem can be solved by introducing new and innovative products.

For instance- TAP, the world's first device that draws blood with a push button, was introduced by Seventh Sense Biosystems. This device is worn on the upper arm and draws blood with the push of a button. This makes high-quality lab testing more convenient and cost-effective.

Restraints/Challenges

• Higher risk related to the capillary blood assortment technologies

Higher risks associated with capillary blood collection technologies and the disadvantages of micro-collection of blood are expected to limit market growth during the forecast period. Capillary blood collection can occasionally cause blood cells to rupture, resulting in inaccurate results. Both methods of collection can cause bleeding and infection.

This capillary blood collection and sampling devices treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the capillary blood collection and sampling devices treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Capillary Blood Collection and Sampling Devices Treatment Market

The COVID-19 pandemic has created both challenges and opportunities in the global market. Due to global travel and trade restrictions, supply chain disruptions of medical devices/equipment and essential medical supplies were common during the pandemic. The virus outbreak, on the other hand, is driving significant growth in the point-of-care (POC) testing devices segment. As the virus spread, the number of infected patients increased rapidly, necessitating increased blood collection via various safety measures for antibody testing.

Recent developments

• In March 2020, B.D. and BioMedomics, a privately held clinical diagnostics company based in North Carolina, announced the development of a 15-minute at-home rapid test to assess current COVID-19 exposure. This is a novel testing device that will increase revenue generation.

Middle East and Africa Capillary Blood Collection and Sampling Devices Treatment Market Scope

The capillary blood collection and sampling devices treatment market is segmented on the basis of product, modality, mode of administration, application, platform, procedure, age group, test type, technology, material, end user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Blood Sampling Devices
• Capillary Blood Collection Devices
• Rapid Test Cassette
• Remote Capillary Blood Collection Device
• Wearable Capillary Blood Collection Device

Modality

• Manual Sampling
• Automated/Autoinjection Sampling

 Mode of Administration

• Puncture
• Incision

Application

• Cardiovascular Disease
• Infection and Infectious Disease
• Respiratory Diseases
• Cancers
• Rheumatoid Arthritis
• Others

 Platform

• Enzyme Immunoassay Platform (Elisa Platform)
• PCR Platform
• Lateral Flow Immunoassay Platform
• ELTABA Platform
• Others

Procedure

• Conventional
• Point of Care Testing

Age Group

• Geriatrics
• Infant
• Pediatric
• Adult

Test Type

• Whole Blood Test
• Dried Blood Spot Tests
• Plasma/Serum Protein Tests
• Liver Panel/Liver Profile/Liver Function Tests
• Comprehensive Metabolic Panel (CMP) Tests
• Others

 Technology

• Volumetric Absorptive Microsampling
• Capillary Electrophoresis-Based Chemical Analysis
• Others

 Material

• Plastic
• Glass
• Stainless Steel
• Ceramic

 End User

• Laboratories
• Home Care Setting

 Distribution Channel

• Direct Tender
• Retail Sales
• Others

Capillary Blood Collection and Sampling Devices Treatment Market Regional Analysis/Insights

The capillary blood collection and sampling devices treatment market is analyzed and market size insights and trends are provided by country, product, modality, mode of administration, application, platform, procedure, age group, test type, technology, material, end user, distribution channel as referenced above.

The countries covered in the capillary blood collection and sampling devices treatment market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

South Africa has control over the Middle East and Africa region due to increased adoption of advanced technology. The Middle East and Africa capillary blood collection and sampling devices market is expanding due to rising health-care costs.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas abajo y aguas arriba, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.

Crecimiento de la infraestructura de atención de salud Base instalada y penetración de nuevas tecnologías

El mercado de dispositivos de recolección y muestreo de sangre capilar también le proporciona un análisis detallado del mercado para cada país: crecimiento del gasto en atención médica para equipos de capital, base instalada de diferentes tipos de productos para el mercado de dispositivos de recolección y muestreo de sangre capilar, impacto de la tecnología mediante curvas de línea de vida y cambios en los escenarios regulatorios de la atención médica y su impacto en el mercado de dispositivos de recolección y muestreo de sangre capilar. Los datos están disponibles para el período histórico 2011-2021.

Análisis del panorama competitivo y de la cuota de mercado de los dispositivos de recogida y muestreo de sangre capilar

El panorama competitivo del mercado de dispositivos de tratamiento de recolección y muestreo de sangre capilar proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas relacionado con el mercado de tratamiento de dispositivos de recolección y muestreo de sangre capilar.

Algunos de los principales actores que operan en el mercado de tratamiento de dispositivos de recolección y muestreo de sangre capilar son:

• BD (Estados Unidos)
• Terumo BCT Inc. (Estados Unidos)
• Fresenius KABI AG (Alemania)
• Grifols SA (España)
• Corporación Médica Nipro (Estados Unidos)
• Greiner AG (Austria)
• Quest Diagnostics Incorporated (Estados Unidos)
• Mitra Industries Private Limited (India)
• SARSTEDT AG & Co. KG (Alemania)
• Biotecnología CML (India)
• Macopharma (Francia)
• Neomedic Limited (Estados Unidos)
• Corporación Haemonetics (Estados Unidos)
• UCI Medical, Inc. (Estados Unidos)
• LABORATORIOS SB-KAWASUMI, INC. (Japón)
• Retractable Technologies Inc. (Estados Unidos)

SKU-54365